Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;81(9):866-70.
doi: 10.1007/s12098-013-1183-8. Epub 2013 Aug 14.

Surgical placement of totally implantable venous access device-an institutional experience

Affiliations
Review

Surgical placement of totally implantable venous access device-an institutional experience

Aravindan Chandrasekaran et al. Indian J Pediatr. 2014 Sep.

Abstract

Objectives: To investigate the advantages and disadvantages of Totally implantable venous access devices (TIVAD) catheter in pediatric age group and also to review this subject in the recent literature and compare the results with the present results.

Methods: A total of 61 cases, 2 mo to 14 y old, were included in the index study. TIVADs were implanted in these patients for chemotherapy. The device was inserted under general anesthesia (GA) by open technique. All the children were followed up for a mean period of 7.2 mo.

Results: Out of 61 cases, 9 cases had complications; 3 requiring removal of the port due to infection and in one case the device had to be reinserted due to malpositioning, one had late wound dehiscence with exposed port chamber which needed operative correction and four had minor wound infections. There was no mortality. Complications like hemo or pneumothorax, arterial puncture, hematoma formation were very less with open technique of insertion of the port. Most patients and their parents were satisfied with TIVAD.

Conclusions: Thus, TIVAD can be a useful device for many chronic patients who need an IV access for multiple injections especially in pediatric age group.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pediatr Hematol Oncol. 2013 Mar;35(2):e71-6 - PubMed
    1. Eur J Surg Oncol. 2008 Feb;34(2):222-6 - PubMed
    1. Ann Surg Oncol. 2010 Jun;17(6):1649-56 - PubMed
    1. Ann Oncol. 1998 Jul;9(7):767-73 - PubMed
    1. Eur J Cancer. 1997 Jul;33(8):1190-4 - PubMed

LinkOut - more resources